Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 480 results for "lupin"

Lupin inks strategic JV agreement with Yoshindo
Bio Spectrum Asia

LUPIN : In bioloogics tie-up with japan's yoshindo

04/25/2014 | 02:10am US/Eastern Recommend: 0 Lupin Ltd has signed an agreement to set up a joint venture with Yoshindo of Japan . The joint venture, YL Biologics, will carry out clinical development in biosimilars. YL Biologics ... 4 Traders, 23 minutes ago
Lupin forms JV with Jap firm The Statesman, 1 day ago
Lupin joint venture with Japan firm The Telegraph, 1 day ago
[x]  

348 images for lupin

Bio Spectrum Asia, 16 hours ago
Bio Spectrum Asia, 20 hours ago
Money Today, 1 day ago
Livemint.com, 1 day ago
Business Standard, 1 day ago
Pharma Letter, 1 day ago
Money Control, 1 day ago
Capsule Computers, 5 days ago
Financial Express, 1 day ago
Business Today India, 1 week ago

If you dont get a decent raise expect a detailed feedback

Companies including Virtusa Corp Dalmia Bharat Group Lupin and Convergys and those in the Tata and HCL groups have offered feedback slips or verbal feedback from bosses to employees to make them know where they lacked
 Hindustan Times11 hours ago If you don't get a decent raise, expect a detailed feedback [Hindustan Times, New Delhi :: ]  BusinessWeek6 hours ago
The Freepress Journal

Lupin aims for a bigger pie in the international market

Indian pharmaceutical major Lupin is looking to increase its global footprint and the joint venture announced with Yoshindo of Japan on Wednesday is one more step in that direction. Lupin is a big player in the cardiovascular, diabetology, asthma, and ...
 The Hindu13 hours ago Recommend Lupin in pharmaceutical space: G Chokkalingam  Economic Times2 months ago Experts say Indian pharma space ripe for consolidation  The Freepress Journal2 weeks ago How will Sun-Ranbaxy look like at the end of the story  VC Circle2 weeks ago
[x]  

Lupin gains after inking JV with Japanese firm

Lupin rose 0.86% to Rs 990.55 at 11:28 IST on BSE after the company said it signed a strategic joint venture agreement with Japan's Yoshindo Inc. The company made the announcement during trading hours today, 23 April 2014. Meanwhile, the BSE Sensex was up ...
 India Infoline1 day ago Lupin gains on JV agreement with Japanese company Yoshindo  Money Control1 day ago Japanese companies showcase...  Siasat Daily1 week ago
Livemint.com

Lupin recalls 9,000 bottles of antibiotic drug

Lupin Pharmaceuticals Inc., a subsidiary of Indian drug maker Lupin Ltd., has initiated a recall of almost 10,000 bottles of an antibiotic product, the U.S. Food and Drug Administration (FDA) has announced. The recall is voluntary and was ...
 Processing Magazine3 days ago Lupin Pulls 9000+ Bottles of Suprax From U.S. Market  Diabetes Care1 week ago Lupin recalls 2 lots of ant...  Siasat Daily1 week ago Lupin pulls over 9,000 bottles of anti-infective Suprax from U.S. -FDA  Reuters1 week ago
[x]  
Bio Spectrum Asia

Lupin ropes in Theresa Stevens to head global M

Mumbai-based pharma major Lupin Ltd has appointed Theresa Stevens as chief corporate development officer for its global operations and will be responsible for global merger and acquisitions (M&A) and specialty business strategy. She joins Lupin ...
 VC Circle2 days ago LUPIN : APPOINTS NEW GLOBAL HEAD  4 Traders1 day ago Lupin Pharmaceuticals, Inc. Appoints As Chief Corporate Development Officer  BioSpace3 days ago Lupin appoints Theresa Stevens as chief corporate development...  Bio Spectrum Asia17 hours ago
[x]  
Business Line

Lupin gets UK regulator's nod for Yinzell & Levonorgestrel Contraceptives

Pharma Major Lupin has received UK regulator's nod for Yinzell & Levonorgestrel Contraceptives. Levonorgestrel is a medicine which is used in contraception. Levonorgestrel contains two hormones that are similar to the hormonesoestrogen and ...
 Indian-Commodity1 week ago Lupin inches up on securing UK regulator's nod for Yinzell & Levonorgestrel contraceptives  Arihant Capital1 week ago Lupin climbs on USFDA nod for generic Actos tablets  New Indian Express2 weeks ago US FDA nod to keep Lupin on investor radars  Business Line2 weeks ago
[x]  

Copycats trip as patent holders hawk variants, tweak dosage

GENERIC drug players like Natco Pharma and Lupin are finding it tough to launch new products, as innovator companies offer different versions of existing drugs before patent expiry, in effect prolonging the patent period and stymieing plans to ...
 Financial Express1 week ago
Business Standard

Indian Based Lupin Pharmaceuticals Exploring U.S. Expansion

By Marcus Johnson Lupin, the Indian drug manufacturer based out of Mumbai, has taken a new step to expand its visibility in the U.S. According to the Baltimore Business Journal , in June, Lupin signed a lease for a 34,000- square-foot location ...
 Pharmaceutical Online1 week ago Lupin to expand Vadodara facility  Business Standard1 month ago Lupin plans to expand Vadodara plant to make antibiotics  Business Standard1 month ago

With rate sensitives getting back into flavor, expect less action in pharma pack: Avinnash Gorakssakar

If you look at Lupin, Sun or Glenmark, despite the fact that there have been some issues on the US FDA front, the core earnings continues to be solid. In an interview with ET Now, Avinnash Gorakssakar, Head of Research, Miintdirect.com, shares his views on ...
 Economic Times2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lupin
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less